Format
Sort by

Send to

Choose Destination

Links from NLM Catalog

Items: 1 to 20 of 444

1.

Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.

Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD.

Harm Reduct J. 2017 Feb 20;14(1):13. doi: 10.1186/s12954-017-0139-0.

2.

Factors that influence children's gambling attitudes and consumption intentions: lessons for gambling harm prevention research, policies and advocacy strategies.

Pitt H, Thomas SL, Bestman A, Daube M, Derevensky J.

Harm Reduct J. 2017 Feb 17;14(1):11. doi: 10.1186/s12954-017-0136-3.

3.
4.

Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.

Wu Q, Kamphuis C, Duo L, Luo J, Chen Y, Richardus JH.

Harm Reduct J. 2017 Feb 14;14(1):10. doi: 10.1186/s12954-017-0137-2.

5.

Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.

Kassai S, Pintér JN, Rácz J, Böröndi B, Tóth-Karikó T, Kerekes K, Gyarmathy VA.

Harm Reduct J. 2017 Feb 10;14(1):9. doi: 10.1186/s12954-017-0138-1.

6.

Harm reduction through housing first: an assessment of the Emergency Warming Centre in Inuvik, Canada.

Young MG, Manion K.

Harm Reduct J. 2017 Feb 7;14(1):8. doi: 10.1186/s12954-016-0128-8.

7.

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario.

Franklyn AM, Eibl JK, Gauthier G, Pellegrini D, Lightfoot NK, Marsh DC.

Harm Reduct J. 2017 Jan 26;14(1):6. doi: 10.1186/s12954-017-0134-5.

8.
9.

Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey.

Crowley D, Collins C, Delargy I, Laird E, Van Hout MC.

Harm Reduct J. 2017 Jan 13;14(1):4. doi: 10.1186/s12954-016-0129-7.

10.
11.

The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia.

Vuong T, Nguyen N, Le G, Shanahan M, Ali R, Ritter A.

Harm Reduct J. 2017 Jan 11;14(1):2. doi: 10.1186/s12954-016-0130-1.

12.

Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam.

Van Nguyen H, Nguyen HL, Mai HT, Le HQ, Tran BX, Hoang CD, Le HT, Nguyen CT, Tran TD, Latkin CA, Vu TM.

Harm Reduct J. 2017 Jan 6;14(1):1. doi: 10.1186/s12954-016-0127-9.

13.

Drug use and health behaviour among German men who have sex with men: Results of a qualitative, multi-centre study.

Deimel D, Stöver H, Hößelbarth S, Dichtl A, Graf N, Gebhardt V.

Harm Reduct J. 2016 Dec 9;13(1):36.

15.
16.

Correlates of sex trading among male non-injecting drug users in Myanmar: a cross-sectional study.

Saw YM, Saw TN, Wai KM, Poudel KC, Win HH.

Harm Reduct J. 2016 Dec 5;13(1):34.

17.

Development of a filter to prevent infections with spore-forming bacteria in injecting drug users.

Alhusein N, Scott J, Kasprzyk-Hordern B, Bolhuis A.

Harm Reduct J. 2016 Dec 1;13(1):33.

18.

Elevated risk of incarceration among street-involved youth who initiate drug dealing.

Hoy C, Barker B, Regan J, Dong H, Richardson L, Kerr T, DeBeck K.

Harm Reduct J. 2016 Nov 22;13(1):32.

19.

An integrated approach to care attracts people living with HIV who use illicit drugs in an urban centre with a concentrated HIV epidemic.

Fernando S, McNeil R, Closson K, Samji H, Kirkland S, Strike C, Turje RB, Zhang W, Hogg RS, Parashar S.

Harm Reduct J. 2016 Nov 22;13(1):31.

20.

Medical cannabis use in Canada: vapourization and modes of delivery.

Shiplo S, Asbridge M, Leatherdale ST, Hammond D.

Harm Reduct J. 2016 Oct 29;13(1):30.

Items per page

Supplemental Content

Support Center